RhyGaze website screenshot

RhyGaze

RhyGaze is a clinical-stage biotechnology company developing gene therapy treatments to restore vision for people with retinal degenerative diseases. Its platform combines optogenetic proteins that engineer photosensitivity into mammalian cells with gene therapy delivery tools that install light-sensing machinery into human eye cells, technology originating at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) in Switzerland. The team includes executives who helped develop and commercialize Luxturna, the first FDA-approved gene therapy for a genetic disease. RhyGaze operates from Basel, Switzerland and Philadelphia, Pennsylvania, and is backed by GV. As a therapeutics company it publishes no public developer API surface.

RhyGaze is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Therapy, and Ophthalmology.

2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0
0 APIs
CompanyLife SciencesBiotechnologyGene TherapyOphthalmologyOptogeneticsVision Restoration

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/rhygaze: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Resources

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: rhygaze
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/rhygaze.png
name: RhyGaze
description: RhyGaze is a clinical-stage biotechnology company developing gene therapy treatments to restore vision for people
  with retinal degenerative diseases. Its platform combines optogenetic proteins that engineer photosensitivity into mammalian
  cells with gene therapy delivery tools that install light-sensing machinery into human eye cells, technology originating
  at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) in Switzerland. The team includes executives who helped
  develop and commercialize Luxturna, the first FDA-approved gene therapy for a genetic disease. RhyGaze operates from Basel,
  Switzerland and Philadelphia, Pennsylvania, and is backed by GV. As a therapeutics company it publishes no public developer
  API surface.
url: https://raw.githubusercontent.com/api-evangelist/rhygaze/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Life Sciences
- Biotechnology
- Gene Therapy
- Ophthalmology
- Optogenetics
- Vision Restoration
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://rhygaze.com
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/rhygaze"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/rhygaze/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/rhygaze/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.